SIS-201-CD

N/A

Report date: 2024/06/28 12:07:06
NMEFirst In Class

Base Information

Drug NameSIS-201-CD
Drug Alias NameSIS-201-CD
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTransforming growth factor beta 1 inhibitors
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsCorneal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSiSaf Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSiSaf Ltd
Inactive CompaniesN/A
Active IndicationsCorneal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A